CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER)
Clinical trial NCT05316181 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05316181
- Sponsor
- National Cancer Center, Korea
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-07
- Primary completion
- 2026-06-30
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.